Search research articles
Contact Us
Filters
Showing results (241-250 of 1,280) with videos related to
Page
of 128
Sort By:
Drugs in R&D
|
May 30, 2018
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
Sebastiano Buti, Maddalena Donini, Melissa Bersanelli, et al.
Minerva Pediatrica
|
November 30, 1979
[Medio-temporal paroxysms without convulsions. Comparison of treated and untreated subjects]
S Borgheresi, E Luti, M R Bardini, et al.
Journal of Hepatology
|
November 4, 2000
Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
M Buti, M A Casado, L Fosbrook, et al.
Digestive Diseases and Sciences
|
November 21, 2001
High-Dose interferon-alpha2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus
M Buti, S Morral, F Sanchez, et al.
Seminars in Liver Disease
|
December 6, 2019
Role of Biomarkers in Guiding Cure of Viral Hepatitis B
Maria Buti, Mar Riveiro-Barciela, Francisco Rodríguez-Frías, et al.
BMC Medical Ethics
|
September 28, 2017
Descriptive study of association between quality of care and empathy and burnout in primary care
Oriol Yuguero, Josep Ramon Marsal, Miquel Buti, et al.
International Journal of Oral Implantology (Berlin, Germany)
|
September 20, 2019
Short implants versus longer implants in vertically augmented atrophic mandibles: A systematic review of randomised controlled trials with a 5-year post-loading follow-up
Marco Esposito, Jacopo Buti, Carlo Barausse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 12, 2024
Letter comments on: Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma
Sara Elena Rebuzzi, Giuseppe Fornarini, Giuseppe Luigi Banna, et al.
Drugs in R&D
|
September 13, 2017
Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
Sebastiano Buti, Maddalena Donini, Melissa Bersanelli, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2013
Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing: Resolving the nitty-gritty
Francisco Rodriguez-Frias, Francisco-Rodriguez Frias, David Tabernero, et al.
Page
of 128
Search research articles
Search
Showing results (241-250 of 1,280) with videos related to
Sort By:
Page
of 128
Drugs in R&D
|
May 30, 2018
Correction to: Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
Sebastiano Buti, Maddalena Donini, Melissa Bersanelli, et al.
Minerva Pediatrica
|
November 30, 1979
[Medio-temporal paroxysms without convulsions. Comparison of treated and untreated subjects]
S Borgheresi, E Luti, M R Bardini, et al.
Journal of Hepatology
|
November 4, 2000
Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C
M Buti, M A Casado, L Fosbrook, et al.
Digestive Diseases and Sciences
|
November 21, 2001
High-Dose interferon-alpha2b plus ribavirin for retreatment of interferon-nonresponsive patients infected with genotype 1 hepatitis C virus
M Buti, S Morral, F Sanchez, et al.
Seminars in Liver Disease
|
December 6, 2019
Role of Biomarkers in Guiding Cure of Viral Hepatitis B
Maria Buti, Mar Riveiro-Barciela, Francisco Rodríguez-Frías, et al.
BMC Medical Ethics
|
September 28, 2017
Descriptive study of association between quality of care and empathy and burnout in primary care
Oriol Yuguero, Josep Ramon Marsal, Miquel Buti, et al.
International Journal of Oral Implantology (Berlin, Germany)
|
September 20, 2019
Short implants versus longer implants in vertically augmented atrophic mandibles: A systematic review of randomised controlled trials with a 5-year post-loading follow-up
Marco Esposito, Jacopo Buti, Carlo Barausse, et al.
European Journal of Cancer (Oxford, England : 1990)
|
May 12, 2024
Letter comments on: Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma
Sara Elena Rebuzzi, Giuseppe Fornarini, Giuseppe Luigi Banna, et al.
Drugs in R&D
|
September 13, 2017
Feasibility, Safety, and Efficacy of an Alternative Schedule of Sunitinib for the Treatment of Patients with Metastatic Renal Cell Carcinoma: A Retrospective Study
Sebastiano Buti, Maddalena Donini, Melissa Bersanelli, et al.
Hepatology (Baltimore, Md.)
|
August 3, 2013
Study of hepatitis B virus quasispecies by ultra-deep pyrosequencing: Resolving the nitty-gritty
Francisco Rodriguez-Frias, Francisco-Rodriguez Frias, David Tabernero, et al.
Page
of 128